This is very similar to the findings in human at early stages of the cardiac disease

ected subcutaneously into the dorsal flank region of C57BL/6 male mice. In separate experiments, serum free conditioned media collected from clone 2 cells was injected twice a week into the tumor site of mice generated by control cells. Tumor length and width were measured every week. After 4 weeks, mice were sacrificed, photographed, tumors were dissected out, weighted and used for YM-155 chemical information histopathological and immunohistochemical studies. The mice were also dissected ventrally, photographed and the metastasized organs such as liver, intestine and kidney were used for histopathological studies. In vivo metastasis study by intra-cardiac injection Control B16F10 and clone 2 cells were injected intracardiacly into anesthetized C57BL/6 male mice. After 3 weeks, mice were sacrificed; photographed, metastasized organs were dissected out and used for histopathological studies. BrdU incorporation assay SK-Mel-28 cells were seeded on coverslip and treated with 100 ng/ml Sema 3A for 24 h followed by incubation with complete media supplemented with BrdU for another 24 h. Cells were fixed with 100% cold methanol and stained with BrdU labeling and detection kit, visualized under fluorescence microscope, photographed and analyzed. Statistical analysis The cell migration, invasion, MTT assays, tumor-endothelial interaction assays, tumor weights and volumes were analyzed statistically. Statistical differences were determined by paired Student’s t test. Differences were considered significant when P,0.05. Wound assay and time laps microscopy To further confirm the motility of control B16F10 and clone 2 cells, wound assay was performed as described. Briefly, clone 2 cells either alone or treated with anti-Sema 3A or antiNRP1 blocking antibody were used for wound assay. In separate experiments, control B16F10 cells either alone or treated with conditioned media obtained from clone 2 were used. After 18 h, wound photographs were taken under inverted microscope. The wound migration was also visualized under time laps Results Expression profile 10411607” of Sema 3A in human melanoma clinical specimens and its correlation with melanoma growth Clinicopathological studies on human melanoma specimens have shown that 10525069” melanoma progression is associated with angiogenesis Semaphorin 3A Attenuates Melanoma Progression . In this study, we have analyzed 8 human melanoma tissue samples and 5 normal skin biopsy samples by histopathology and immunohistochemistry. The clinical samples were collected from local hospital with informed consent. The occurrences of melanoma in these samples were examined by H&E staining and the micrographs were taken in 106 magnification. The expression level of Sema 3A in these samples was determined by immunohistochemistry using anti-Sema 3A antibody. The results revealed that significant expression of Sema 3A was observed in normal skin biopsy specimens. However, the level of Sema 3A was significantly reduced in all 8 melanoma tissue sections indicating that loss of Sema 3A level may be linked with melanoma growth. Taken together, these data suggested that loss of Sema 3A expression is associated with melanoma progression in human clinical specimens. Generation of Sema 3A clone in murine melanoma cells To examine the endogenous level of Sema 3A, we have used two different murine melanoma cell lines. Our RT-PCR and Western blot analysis data revealed that low metastatic melanoma cells express significantly higher level of Sema 3A as compared to highly metasta